BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3862427)

  • 1. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.
    Webster MA; Phipps SL; Gillmer MD
    Br J Obstet Gynaecol; 1985 Sep; 92(9):963-8. PubMed ID: 3862427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myometrial activity in first trimester human pregnancy after Epostane therapy. Effect of intravenous oxytocin.
    Webster MA; Pattison NS; Phipps SL; Gillmer MD
    Br J Obstet Gynaecol; 1985 Sep; 92(9):957-62. PubMed ID: 3862426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
    Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of abortion in early first trimester human pregnancy using epostane.
    Webster MA; Gillmer MD
    Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M; Van Look PF
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.
    Crooij MJ; de Nooyer CC; Rao BR; Berends GT; Gooren LJ; Janssens J
    N Engl J Med; 1988 Sep; 319(13):813-7. PubMed ID: 3166108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1136-40. PubMed ID: 6594157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intracervical PGE2-gel on myometrial activity and cervical state in first trimester pregnancy.
    Forman A; Ulmsten U; Wingerup L; Bányai J
    Prostaglandins; 1982 Sep; 24(3):303-12. PubMed ID: 6961477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of prostaglandin E2 pessaries and laminaria tents for ripening the cervix before termination of pregnancy.
    Killick SR; Vaughan Williams CA; Elstein M
    Br J Obstet Gynaecol; 1985 May; 92(5):518-21. PubMed ID: 3857938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane.
    Pattison NS; Webster MA; Phipps SL; Anderson AB; Gillmer MD
    Fertil Steril; 1984 Dec; 42(6):875-81. PubMed ID: 6437877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Epostane on progesterone synthesis in early human pregnancy.
    Birgerson L; Odlind V; Johansson ED
    Contraception; 1986 Apr; 33(4):401-10. PubMed ID: 3731777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
    Fisher PR; Taylor JH
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine contractility during pregnancy and the effect of abortifacient drugs.
    Bygdeman M; Swahn ML
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):249-61. PubMed ID: 2225598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of early human pregnancy with epostane.
    Birgerson L; Olund A; Odlind V; Somell C
    Contraception; 1987 Feb; 35(2):111-20. PubMed ID: 3595138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.